NEOADJUVANT THERAPY
Clinical trials for NEOADJUVANT THERAPY explained in plain language.
Never miss a new study
Get alerted when new NEOADJUVANT THERAPY trials appear
Sign up with your email to follow new studies for NEOADJUVANT THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug combo shrinks tumors, saves kidneys in High-Risk cancer
Disease control CompletedThis study tested whether giving two drugs, cadonilimab and lenvatinib, before surgery could shrink high-risk kidney tumors enough to allow for a kidney-sparing operation. It involved 39 patients with localized kidney cancer for whom surgery was difficult. The goal was to see if …
Matched conditions: NEOADJUVANT THERAPY
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New drug combo aims to shrink tumors before lung cancer surgery
Disease control CompletedThis study tested whether adding the immunotherapy drug serplulimab to standard chemotherapy, given both before and after surgery, could help people with operable non-small cell lung cancer. The goal was to see if this combination could shrink tumors more effectively before surge…
Matched conditions: NEOADJUVANT THERAPY
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Blood test breakthrough predicts pancreatic cancer survival
Knowledge-focused CompletedThis study looked back at 300 pancreatic cancer patients to see if a blood test could help predict their outcomes. The test measures changes in cancer cells circulating in the blood, especially during pre-surgery treatment. Researchers found that tracking these cell changes could…
Matched conditions: NEOADJUVANT THERAPY
Sponsor: Guo ShiWei • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:29 UTC
-
Researchers track how chemo saps strength in breast cancer fight
Knowledge-focused CompletedThis study aimed to understand how chemotherapy given before surgery affects the physical abilities of women with breast cancer. Researchers measured the strength, balance, activity levels, and fatigue of 67 participants before and after their chemotherapy treatment. The goal was…
Matched conditions: NEOADJUVANT THERAPY
Sponsor: ATİYE KAŞ ÖZDEMİR • Aim: Knowledge-focused
Last updated Mar 11, 2026 14:54 UTC